Clinical analysis of Mycoplasma pneumoniae pneumonia combined with adenovirus infection in children with lobar pneumonia
- PMID: 40563048
- DOI: 10.1007/s10096-025-05194-6
Clinical analysis of Mycoplasma pneumoniae pneumonia combined with adenovirus infection in children with lobar pneumonia
Abstract
Objective: Mycoplasma pneumoniae (MP) is a major pathogen that causes community-acquired pneumonia in children with a high rate of co-infection. Human adenovirus (HAdV) is a common co-infecting pathogen. This study aimed to analyze the clinical characteristics of children with lobar pneumonia caused by co-infection with MP and HAdV, and to investigate the correlation between the MP mutation sequence ratio (mutation depth/MP count) and HAdV sequence count with disease severity, thus providing evidence for clinical diagnosis and treatment.
Methods: Children with MP-infected lobar pneumonia hospitalized in the Department of Pediatric Respiratory Medicine at the First Hospital of Jilin University from September to November 2023 were enrolled in this study and divided into MP and MP + HAdV groups. Clinical manifestations, laboratory examinations, and treatments were compared between the two groups. Correlations of the MP mutation sequence ratio and HAdV sequence count with clinical manifestations, laboratory examinations, and treatments were analyzed.
Results: A total of 154 children with MP lobar pneumonia were included, with 96 cases in the MP group and 58 cases in the MP + HAdV group. The results showed that the MP + HAdV group had a longer total disease duration, fever duration, intravenous anti-MP drug administration duration, and systemic corticosteroid application duration, with a higher proportion of intravenous immunoglobulin use. The MP group had higher CRP levels and a higher incidence of pulmonary necrosis. After 10 days of treatment, the MP group showed better improvement in the pneumonia volume than the MP + HAdV group. There were no significant differences between the two groups in the length of hospital stay, peak fever, wheezing and rash, oxygen therapy proportion, or second-line anti-MP drug usage. No significant differences were observed between the two groups in the WBC, ESR, LDH, D-dimer, albumin, ALT, ferritin levels, incidence of atelectasis, pleural effusion, or bronchoscopy findings.
Conclusion: Co-infection with HAdV can exacerbate the condition of children with MP lobar pneumonia and increase treatment difficulty. Higher MP mutation sequence ratios are associated with more severe airway mucosal damage, and higher HAdV viral loads correlate with more severe disease.
Keywords: Mycoplasma pneumoniae; Children; Clinical features; Human adenovirus; Lobar pneumonia.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics approval: Ethics approval approved by The First Hospital of Jilin University (Approval Number No. 2024–689). Conflicts of interest: The authors declare no competing interests.
Similar articles
-
Clinical features and risk factors for severe macrolide-resistant mycoplasma pneumoniae pneumonia induced by 23 S rRNA A2063G mutation: a retrospective observational study.Eur J Clin Microbiol Infect Dis. 2025 Jul 17. doi: 10.1007/s10096-025-05215-4. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2025. PMID: 40676488
-
Volume ratio of pulmonary lesions as a novel indicator for predicting the occurrence of plastic bronchitis in children with Mycoplasma pneumoniae pneumonia.Eur J Pediatr. 2025 Jun 9;184(7):409. doi: 10.1007/s00431-025-06251-0. Eur J Pediatr. 2025. PMID: 40490539
-
Exploration of the Therapeutic Efficacy of Azithromycin Sequential Therapy in Children With Mycoplasma Pneumonia.Br J Hosp Med (Lond). 2025 Jun 25;86(6):1-18. doi: 10.12968/hmed.2025.0005. Epub 2025 Jun 13. Br J Hosp Med (Lond). 2025. PMID: 40554432
-
Delayed antibiotics for symptoms and complications of respiratory infections.Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004417. doi: 10.1002/14651858.CD004417.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004417. doi: 10.1002/14651858.CD004417.pub3. PMID: 15495108 Updated.
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
References
-
- Catherine K, Cynthia C (2020) Mycoplasma pneumonia in children and adolescents. Pediatr Rev 41. https://doi.org/10.1542/pir.2018-0016
-
- Subspecialty Group of Respiratory t. S. o. P. C. M. A., China National Clinical Research Center of Respiratory D, Editorial Board, C. J. o. P (2024) [Evidence-based guideline for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023)]. Zhonghua Er Ke Za Zhi 62:1137–1144. https://doi.org/10.3760/cma.j.cn112140-20240722-00503
-
- Contes KM, Liu BM (2025) Epidemiology, clinical significance, and diagnosis of respiratory viruses and their co-infections in the post-COVID era. Pathogens 14:262. https://doi.org/10.3390/pathogens14030262 - DOI - PubMed - PMC
-
- Shaden J, Randa K, Jamal S, Hiyam M, Musa H (2018) Adenovirus respiratory tract infections in infants: a retrospective chart-review study. Lancet. https://doi.org/10.1016/s0140-6736(18)30409-4 - DOI
-
- Wen S et al (2021) The epidemiology, molecular, and clinical of human adenoviruses in children hospitalized with acute respiratory infections. Front Microbiol 12:629971. https://doi.org/10.3389/fmicb.2021.629971 - DOI - PubMed - PMC
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous